AUTHOR=Chen Song , Fang Fang , Liu Wenjun , Liu Chengjun , Xu Feng 

TITLE=Cerebral Tissue Regional Oxygen Saturation as a Valuable Monitoring Parameter in Pediatric Patients Undergoing Extracorporeal Membrane Oxygenation

JOURNAL=Frontiers in Pediatrics

VOLUME=9

YEAR=2021

URL=https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2021.669683

DOI=10.3389/fped.2021.669683

ISSN=2296-2360

ABSTRACT=<p><bold>Objective:</bold> Brain function monitoring technology for extracorporeal membrane oxygenation (ECMO) support has been developing quite slowly. Our objective was to explore the data distribution, variation trend, and variability of cerebral tissue regional oxygen saturation (CrSO<sub>2</sub>) in pediatric patients undergoing ECMO.</p><p><bold>Methods:</bold> Eight patients who received venoarterial ECMO (V-A ECMO) were included in our study. All of them accepted continuous CrSO<sub>2</sub> monitoring by near-infrared spectroscopy (NIRS) within 12 h of ECMO initiation until ECMO wean. Differences in the CrSO<sub>2</sub> distribution characteristic, the variation trend of daily CrSO<sub>2</sub>, and the variability of CrSO<sub>2</sub> for the first 5 days following ECMO initiation were compared between survivors and non-survivors according to pediatric intensive care unit (PICU) mortality.</p><p><bold>Results:</bold> The percentage of time of CrSO<sub>2</sub> &lt;60% against the whole monitoring time was significantly lower in survivors in both hemispheres {right: 4.34% [interquartile range (IQR) = 0.39–8.55%] vs. 47.45% [IQR = 36.03–64.52%], <italic>p</italic> = 0.036; left: 0.40% [IQR = 0.01–1.15%] vs. 30.9% [IQR = 26.92–49.62%], <italic>p</italic> = 0.036}. Survivors had significantly higher CrSO<sub>2</sub> on the first 4 days. Root mean of successive squared differences (RMSSD), the variability variable of CrSO<sub>2</sub>, was significantly lower in survivors (right: 3.29 ± 0.79 vs. 6.16 ± 0.67, <italic>p</italic> = 0.002; left: 3.56 ± 1.20 vs. 6.04 ± 1.44, <italic>p</italic> = 0.039).</p><p><bold>Conclusion:</bold> Lower CrSO<sub>2</sub>, CrSO<sub>2</sub> &lt;60% over a longer period of time, and higher fluctuation of CrSO<sub>2</sub> are likely associated with PICU mortality in pediatric patients undergoing V-A ECMO.</p><p><bold>Clinical Trial Registry:</bold> URL: <ext-link ext-link-type="uri" xlink:href="http://www.chictr.org.cn/showproj.aspx?proj=46639" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.chictr.org.cn/showproj.aspx?proj=46639</ext-link>, trial registry number: ChiCTR1900028021.</p>